To circumvent loss of antigen expression, Lee et al. [106] hypothesized that dual-antigen targeting of BCMA and TACI by the shared antigen a proliferation-inducing ligand (APRIL) would decrease the possibility for tumor escape. Here, TNFRSF17 is linked to neoplasm.